RePub, Erasmus University Repository

Assessment of post-stroke quality of life in cost-effectiveness studies: The usefulness of the Barthel Index and the EuroQoL-5D Article

Quality of Life Research, 13(2), 427-433.

N.J.A. van Exel (Job), W.J.M. Scholte op Reimer (Wilma) and M.A. Koopmanschap (Marc)

March 2004
Classification and Current Treatment Options of In-Stent Restenosis: Present Status and Future Perspectives Review

A.T.L. Ong (Andrew), J. Aoki (Jiro), E.P. McFadden (Eugene) and P.W.J.C. Serruys (Patrick)

March 2004
Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapy Article

HIV Medicine, 5(2), 74-81.

F. van Leth (Frank), F.W.N.M. Wit (Ferdinand), P. Reiss (Peter), J.K.M.E. Schattenkerk (J. K M E), M.E. van der Ende (Marchina), M.M.E. Schneider (Margriet M.), J.W. Mulder (Jan-Willem), P.H.J. Frissen, F. de Wolf (Frank) and J.F. Lange (Johan)

March 2004
The significance of angiogenesis in malignant pheochromocytomas Article

Endocrine Pathology, 15(1), 39-45.

P.P.G.M. Rooijens, R.R. de Krijger (Ronald), H.J. Bonjer (Jaap), F. van der Ham (Frieda), A.L. Nigg (Alex), H.A. Bruining (Hajo), S.W.J. Lamberts (Steven) and E. van der Harst (Erwin)

March 2004
Alexithymia Does Not Predict the Persistence of Medically Unexplained Physical Symptoms Article

Psychosomatic Medicine, 66(2), 224-232.

C.G. Kooiman (Cornelis), J.H. Bolk (Jan), H.G.M. Rooijmans (Harry G.) and R.W. Trijsburg (Wim)

March 2004
Epidemiology of non-AD dementias Review

M. Bornebroek (Marjolijn) and M.M.B. Breteler (Monique)

March 2004
Potentially Advanced Malignancies Detected by Screening for Prostate Carcinoma after an Interval of 4 Years Article

Cancer, 100(5), 968-975.

R. Postma (Renske), M.J. Roobol-Bouts (Monique), F.H. Schröder (Fritz) and Th.H. van der Kwast (Theo)

March 2004
Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group Article

European Journal of Cancer, 40(5), 689-695.

M. Debiec-Rychter (Maria), H. Dumez (Herlinde), I.R. Judson (Ian), B. Wasag (B.), J. Verweij (Jaap), M. Brown (M.), S. Dimitrijevic (Sasa), R. Sciot (Raf), M. Stul (Michel), H. Vranck (H.), et al.

March 2004

Publication

Assessment of post-stroke quality of life in cost-effectiveness studies: The usefulness of the Barthel Index and the EuroQoL-5D Article

Classification and Current Treatment Options of In-Stent Restenosis: Present Status and Future Perspectives Review

Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapy Article

The significance of angiogenesis in malignant pheochromocytomas Article

Alexithymia Does Not Predict the Persistence of Medically Unexplained Physical Symptoms Article

Epidemiology of non-AD dementias Review

Potentially Advanced Malignancies Detected by Screening for Prostate Carcinoma after an Interval of 4 Years Article

Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group Article

About

Publication

Assessment of post-stroke quality of life in cost-effectiveness studies: The usefulness of the Barthel Index and the EuroQoL-5D Article

Classification and Current Treatment Options of In-Stent Restenosis: Present Status and Future Perspectives Review

Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapy Article

The significance of angiogenesis in malignant pheochromocytomas Article

Alexithymia Does Not Predict the Persistence of Medically Unexplained Physical Symptoms Article

Epidemiology of non-AD dementias Review

Potentially Advanced Malignancies Detected by Screening for Prostate Carcinoma after an Interval of 4 Years Article

Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group Article

Workflow

Workflow

Add Content